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Summary: A lipid, stable to alkaline methanolysis, is formed when liver mito- 
chondria or brain microsomes are incubated with dihydroxyacetone phosphate, long 
chain alcohol, ATP, CoA, NaF and Mg*. The lipid has been identified as alkyl 
dihydroxyacetone phosphate. This lipid is reduced by NADPH to 1-alkyl glycerol- 
3-phosphate and is further acylated to form 1-alkyl 2-acyl glycerol-3-phosphate. 
The ether-containing lipids are very widespread in nature (1). Recently 
Snyder and coworkers (2,3) presented evidence that these lipids are formed in 
tumor cells from long chain alcohol and D-glyceraldehyde-3-phosphate (GADP)'. 
During the course of investigation of DHAP-containing lipid, it was found that 
an alkyl-ether-containing lipid is biosynthesized in normal guinea pig liver 
mitochondria or in mouse brain microsomes from long chain alcohol and DHAP in 
the presence of necessary cofactors. Evidence presented here indicates that 
GADP is not an obligatory intermediate in this system. 
Materials and Methods: 1-14C-Hexadecanol was purchased from Amersham/Searle 
(Des Plaines). 32 P-Labeled DHAP was prepared by enzymatic phosphorylation of 
dihydroxyacetone (4). Labeled fructose-6-phosphate was prepared by enzymatic 
(hexokinase) phosphorylation of fructose by y- 32 P-ATP and oxidized with periodic 
acid (5) to form =P-GADP. Crystalline enzymes were from Boehringer-Mannheim 
(New York). Hexadecanol was emulsified in Tris-HCl buffer (0.1 M, pH 7.6) with 
Triton X-100 (Rohm and Haas, Philadelphia). 
Incubation conditions are described in Table 1. The reaction was stopped 
by adding 4.5 ml chloroform-methanol (l-2) and the lipid was extracted as 
1 Abbreviations used: GADP - D-glyceraldehyde-3-phosphate; DHAP - dihydroxy- 
acetone phosphate; GP - glycerol-3-phosphate. 
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Table 1. Requirements for the incorporation of 32 P-DHAP into alkali-stable 
lipid. 
The incubation mixture contained Tris-HCl buffer (pH 7.6, 40 mM), MgC12 
(4.2 mM), ATP (8.4 mM), NaF (8.4 mM), glutathione (4.2 mM), CoA (.04 mM), 
hexadecanol (0.5 mg), Triton X-100 (0.5 mg), 32P-DHAP (0.6 mM, 7x10' cpm in 
expt. A and 9x105 cpm in expt. B) and either guinea pig liver mitochondria 
(expt. A, 1.6 mg protein) or mouse brain (13-15 days old) microsomes (expt. B, 
3.0 mg protein) in a total volume of 1.2 ml. The mixture was incubated at 37" 
for 1 hr. The radioactivity in the alkali-stable lipid was determined as 
described in the text. 
System 
Expt. A 
Radioactivity in alkali- 
stable-lipid 
Expt. B 









+ NADPH (0.84 mM) 
+ NADPH (0.84 mM)* 
- hexadecanol, 













+ palmitaldehyde (0.5 mg) 310 
* 
Added after 30 min incubation. 
described previously (6). To the dry lipid 1.3 ml of chloroform, 0.25 ml 
methanol and 0.4 ml of 0.5 N NaOH in methanol were added. The alkaline 
methanolysis treatment was stopped after 10 min by adding 0.5 ml of 6 N H3P04. 
After mixing and centrifuging, the upper layer was removed and the lower layer 
was washed with 1 ml chloroform-methanol-water (3-48-47). The radioactivity 
in an aliquot of the lower layer was determined. When formation of alkali- 
stable lipid from 1-C 14 -hexadecanol was determined, the unconverted radioactive 
substrate was removed by chromatography on a silicic acid column. Other method: 
and materials were described previously (4,7,8). 
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Cofactor requirements: The requirements for the formation of alkali-stable 
lipid are given in Table 1. It is seen that ATP, CoA and NaF are necessary. 
F- probably inhibits the hydrolysis of phosphomonoester bonds. Mg ++ was found 
to increase the activity. Addition of EDTA completely inhibited the enzymatic 
activity and Mg +I- could partially restore the activity. The long chain alcohol 
could not be replaced by a long chain aldehyde or a long chain fatty acid 
(Table 1) or by hexadecyl phosphate. When 32P-GP was used instead of 32P- 
DHAP, no alkali-stable lipid was formed. However, alkali-stable lipid was 
formed when 32 P-GADP was used instead of DHAP (see below). NADPH was found to 
inhibit the formation of the lipid (Table 1); however, if NADPH was added some 
time after the start of the incubation, the properties of biosynthesized lipid 
were different (see below). NADH partly inhibited the reaction. The 
requirements for the incorporation of 1-C 14 -hexadecanol in the presence of 
DHAP into alkali-stable lipid were found to be similar as shown in Table 1. 
Characterization of the lipids: The 32 P- and l4 C-labeled alkali-stable lipids 
were found to have chromatographic properties similar to acyl DHAP (Fig. 1). 
However, the former lipid is not hydrolyzed by alkali (1 N, 10 min at 37') or 
by acid (1 N, 10 min at 100'). The lipid was also found to be stable towards 
acid in the presence of HgC12 unlike alkenyl ethers. When reduced with NaBH4 
(a), the chromatographic properties of the lipid became similar to lyso- 
phosphatidic acid (Fig. 1). The reduced lipid was also stable towards acid 
and alkali. When NADPH was added to the incubation mixture after 30 min of 
incubation the resulting phospholipid was found to migrate with phosphatidic 
acid (Fig. 1). After alkaline methanolysis this lipid had a migration rate 
similar to that of lysophosphatidic acid. When the lipid that was formed in the 
presence of NADPH (Fig. 1C) was treated with snake venom phospholipase A, the 
major resultant lipid had chromatographic properties similar to that of lyso- 
phosphatidic acid. 
The presence of ether linkage was confirmed by treatment of the alkali- 
stable lipid formed from 1-C 14 -hexadecanol and 32P-DHAP by LiAlH4 (9,lO). The 
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Fig. 1. Autoradiogram of 32P- and l4 C-labeled lipids after separation by thin 
layer chromatography (7) formed under va;$ous conditions. A. Radioactive lipid 
formed by incubation of hexadecanol and P-DHAP with various cofactors in 
liver mitochondria (see Table 1, expt. A). Both alkali-stable lipid and acyl 
DHAP formed with endogenous fatty acid are present. 2. The lipid in A after 
alkaline methanolysis. 5. Radioactive lipid formed when NADPH is added after 
30 min to the incubation mixture. The most rapidly moving spot is a mixture of 
a small amount of diacyl GP and alkyl acyl GP. 2. Lipid in C after alkaline 
methanolysis. 3. The lipid as in B after NaBH4 reduction. E - I. Same as A - D 
but brain microsomes were used instead of liver mitochondria. .I. The radioactive 
lipid formed from 1-C14-hexadecanol and DHAP in liver mitochondria after alka- 
line methanolysis. -, K C14-lipid formed before alkaline methanolvsis from l-C14- 
hexadecanol when NADPH is present 
The positions of known lipids are 
(3) diacyl GP. 
. &. Lipid in K after alkaline-methanolysis. 
also shown. (1) acyl DHAP. (2) acyl GP. 
32 P became water soluble and the 1 4 C-lipid took on the behavior of chimyl 
alcohol with which it comigrated in various chromatographic systems (10). When 
this product was treated with NaI04 the product migrated with the NaI04 oxida- 
tion product of chimyl alcohol. 
The evidence presented above suggests the formation of alkyl ether 

















I II III 
Scheme 1. 
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The presence of an alkyl ether group and its position is inferred by 
resistance of the lipid to hydrolysis by acid or alkali, the nature of the 
product formed after LiA1H4 treatment and the subsequent oxidation of the 
neutral lipid formed by periodate. The presence of an acyl group in III is 
indicated by hydrolysis by alkali and snake venom. The acyl group comes from 
endogenous fatty acid. The hydrolysis by snake venom indicates further that 
glycerol is likely present in L-configuration (11). The presence of a 
carbonyl group in I is suggested by its formation from DHAP, its chromatographic 
properties and its reduction by NaBH4. The reduction of alkyl DHAP by NADPH is 
probably similar to the reduction of acyl DHAP (12). 
D-glyceraldehyde-3-phosphate vs. dihydroxyacetone phosphate: As mentioned 
above, 32 P-GADP also acted as a substrate in the formation of the ether- 
containing lipid. The requirements and the nature of the lipid formed were 
identical to that from DHAP. Either triose phosphate might be the true 
reactant, since they are rapidly interconverted by triose phosphate isomerase. 
TIME (MIN) 
Fig. 2. Time course of formation of radioactive alkali-stable lipid from either 
32P-DHAP or 32P-GADP in Tris (60 mM) or phosphate (60 mM) buffers. The incu- 
bation condition is similar to that described in Table 1. 
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Considerable amount of isomerase activity was found in liver mitochondria or 
brain microsome which could not be completely removed by repeated washing (13). 
Several lines of evidence have been found which suggest that DHAP is not 
converted to GADP in the incubation mixture, and is the actual substrate for 
ether formation. When a time course of the formation of alkali-stable lipid 
from either DHAP or GADP was determined, a small but consistent lag of the 
formation of lipid from jLP-GADP was found (Fig. 2). The lag was more 
pronounced in phosphate buffer than in Tris buffer (Fig. 2) and it is known 
that phosphate partially inhibits triose phosphate isomerase (14). When GADP 
dehydrogenase was added to the incubation mixture, the incorporation of GADP 
was inhibited without much effect on DHAP incorporation (Table 2). On the 
other hand, addition of GP-dehydrogenase was found to inhibit the incorporation 
of both GADP and DHAP (Table 2). Hydrazine (1 mM) was found to inhibit GADP 
incorporation more than DHAP incorporation. 
5!!b1e 2. 
Effect of addition of different agents on the incorporation of 
P-DHAP and 32P-GADP into alkali-stable lipid. 
The reaction mixture is similar to the ohe described in Table 1, expt. A. 
Either 32P-DHAP (0.6 pmole, 1.2~10~ cpm) or '2P-GADP (0.6 pmole, 1.1~10~ cpm) 
were used. Other additions were as stated below. The incubation was at 37" 
for 15 min. 
Addition Radioactive Radioactivity in alkali 
substrate stable lipid 
NAD (1 pmole), Arsenate (1 pmole) 
NAD (1 umole), Arsenate (1 pmole 
+ GADP dehydrogenase (40 pg) 
NADH (1 pmole) 
NADH (1 pmole) + GP dehydrogenase 
(50 w2) 
NAD (1 pmole), Arsenate (1 pmole) 
NAD (1 pmole), Arsenate (1 pmole) 
+ GADP dehydrogenase (40 pg) 
NADH (1 umole) 
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These results support the proposed pathway for the biosynthesis of alkyl- 
ether containing lipid shown in scheme 1. The alkyl acyl GP is further metabo- 
lized by known pathways to form diacyl alkyl glycerol or complex phospholipids 
There are reports that plasmalogens may be biosynthesised from glycerol ethers 
(15), although in the present system no formation of plasmalogen was found. 
Addition of NAD stimulated the formation of alkali-stable lipid but the nature 
of the product was unchanged. 
The present system is similar in many respects to the system found in 
preputial gland tumors (2), especially in the requirements of cofactors. 
However, the specificity of acceptor is different. It will be of interest to 
elucidate the role of ATP and CoA. Further aspects of this novel biosynthesis 
of alkyl ether bond are under investigation in this laboratory. 
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